We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byNatalie Kearney
Modified over 2 years ago
Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56
Baseline Characteristics of the Study Population Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56
Angiographic and Procedural Characteristics Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56
Characteristics of Patients With Definite or Probable ST Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56
Kaplan-Meier analysis for the cumulative incidence of stent thrombosis (A) and for the composite of death or stent thrombosis (B) Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56
Distribution of ST Across Quintiles Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56
Clinical Outcome Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56
Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:
Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:
Five year clinical follow-up of the PASSION-trial Five year clinical follow-up of the PASSION-trial Five Year Follow-up after Primary PCI with a Paclitaxel-Eluting.
The EMERALD Trial Diabetic Substudy. EMERALD Diabetic Analysis To compare myocardial perfusion and infarct sizes in diabetic and non-diabetic patients.
Oxford The John Radcliffe Hospital Multi-vessel disease… Le Mans implications Dr Adrian Banning.
Statin Landmark Trials Across the Spectrum of Risk: Secondary CV Prevention.
NAPLES Novel Approaches for Preventing or Limiting Event Study Randomised Comparison of Bivalirudin Monotherapy versus Unfractionated Heparin plus Tirofiban.
ACC/AHA Classification of Care Metrics Clinical performance measures: Those measures specifically suitable for public reporting, external comparisons,
Optimal revascularization strategy in patients with three-vessel disease and/or left main disease The 2-year Outcomes of the SYNTAX Trial A. Pieter Kappetein,
Angiographic Features of Atherosclerotic Superficial Femoral Artery Disease in Diabetics and Non-diabetics Presenting with Claudication Atif Mohammad,
HIV-infection in Russia Alexander Panteleev Head of the HIV/TB department City TB Hospital # 2, St-Petersburg, Russia.
NAPLES III Novel Approaches in Preventing or Limiting Event III TriaL Randomised Comparison of Bivalirudin versus Unfractionated Heparin in Patients at.
Dip.di SCIENZE CARDIOVASCOLARI POLICLINICO UMBERTO I Dip.di SCIENZE CARDIOVASCOLARI POLICLINICO UMBERTO I Impact of Thromboaspiration during Primary PCI.
Workshop 4: Il late-presenter Moderatori: G. Ippolito, M. Moroni Discussant: R. Iardino Risposta virologico-clinica e scelta della terapia C. Mussini.
Social deprivation, ethnicity and access to kidney transplantation in England and Wales Udaya Udayaraj.
A Prospective, Randomized Comparison of Paclitaxel-eluting TAXUS Stents vs. Bare Metal Stents During Primary Angioplasty in Acute Myocardial Infarction.
A Prospective, Randomized Comparison of Bivalirudin vs. Heparin Plus Glycoprotein IIb/IIIa Inhibitors During Primary Angioplasty in Acute Myocardial Infarction.
Giancarlo Agnelli Università di Perugia Anticoagulant treatment for PE: optimal duration.
Predictors of Acute, Subacute and Late Stent Thrombosis After Acute MI Primary Angioplasty in the Horizons AMI Trial George D. Dangas, Alexandra J. Lansky,
Cardiopatia ischemica: nuovi orizzonti nella terapia con antiaggreganti orali Giancarlo Casolo Genova, Hotel NH Marina 21/22 Ottobre 2011 HEARTLINE HSM.
patients, 51 countries, 1139 centers Fox K, Ford I, Steg PG, Tardif JC, Tendera M, Ferrari R. Rationale, design, and baseline characteristics of.
Harvard Medical School Coronary MDCTA Applications Thomas H. Hauser MD, MMSc, MPH, FACC Director of Nuclear Cardiology Beth Israel Deaconess Medical Center.
Associations Between Outpatient Heart Failure Process of Care Measures and Mortality Gregg C. Fonarow, Nancy M. Albert, Anne B. Curtis, Mihai Gheorghiade,
St Marys Hospital Ingrid V. Bassett, MD, MPH Massachusetts General Hospital Harvard Medical School May 25, 2010 Who Starts ART in Durban, South Africa?
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 ICD data.
Survival Analysis In many medical studies, the primary endpoint is time until an event occurs (e.g. death, remission) Data are typically subject to censoring.
Impact of Diabetes Mellitus on Early and Long-term Results of Percutaneous Drug- eluting Stent Implantation for Unprotected Left Main Coronary Disease.
VALIDATING AHRQ PATIENT SAFETY INDICATORS with the VA NATIONAL SURGICAL QUALITY IMPROVEMENT PROGRAM POSTOPERATIVE ADVERSE EVENTS Dennis Tsilimingras, M.D.,
Essentials of CKD Comorbidities and outcomes in CKD.
Doppia antiaggregazione dopo impianto di DES: prolungata... ma non troppo? Doppia antiaggregazione dopo impianto di DES: prolungata... ma non troppo? UO.
© 2016 SlidePlayer.com Inc. All rights reserved.